| 38.23 |  +0.25 / +0.66%Today’s Change | 31.56 Today|||52-Week Range 43.84 | +8.18% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $53.2B |
Company Description
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Employees
Shareholders
| Mutual fund holders | 56.41% |
| Other institutional | 38.26% |
| Individual stakeholders | 1.46% |
Top Executives
| Michael F. Mahoney | Chairman, President & Chief Executive Officer |
| Edward Mackey | Executive Vice President-Operations |
| Daniel J. Brennan | Chief Financial Officer & Executive Vice President |
| Jodi Eddy | Chief Information Officer & SVP |
| Ian T. Meredith | Global Chief Medical Officer & Executive VP |
+0.25 / +0.66%
